Invention Grant
- Patent Title: Methylphenidate extended release chewable tablet
- Patent Title (中): 哌甲酯延长释放咀嚼片
-
Application No.: US14300580Application Date: 2014-06-10
-
Publication No.: US08999386B2Publication Date: 2015-04-07
- Inventor: Yu-Hsing Tu , Ashok Perumal , Kalyan Kathala
- Applicant: TRIS Pharma, Inc.
- Applicant Address: US NJ Monmouth Junction
- Assignee: TRIS Pharma, Inc.
- Current Assignee: TRIS Pharma, Inc.
- Current Assignee Address: US NJ Monmouth Junction
- Agency: Howson & Howson LLP
- Main IPC: A61K9/22
- IPC: A61K9/22 ; A61K31/4458 ; A61K9/20 ; A61K9/00 ; A61K9/50

Abstract:
An oral methylphenidate extended release tablet is described, which can be scored and still retain its extended release profile. The tablet contains a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and an uncomplexed methylphenidate active component. Following administration of a single dose of the extended release methylphenidate chewable tablet, a therapeutically effective amount of methylphenidate is reached in less than about 20 minutes and the composition provides a twelve-hour extended release profile.
Public/Granted literature
- US20140287041A1 Methylphenidate Extended Release Chewable Tablet Public/Granted day:2014-09-25
Information query